— Know what they know.
Not Investment Advice

AKAN NASDAQ

Akanda Corp.
1W: -35.1% 1M: -47.1% 3M: -83.7% YTD: -79.9% 1Y: -97.1% 3Y: -99.9%
$1.98
-0.23 (-10.41%)
 
Weekly Expected Move ±14.2%
$1 $2 $2 $2 $3
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 29 · $64085 mcap · 32174 float · 3225.93% daily turnover · Short 37% of daily vol
Smart Money Score
Watch 25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$0.1M
52W Range1.94-78.9
Volume218,885
Avg Volume1,037,911
Beta1.73
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKatharyn Field
Employees8
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-03-15
100 King St. W
Toronto, ON M5X 1G5
CA
44 20 3488 9514
About Akanda Corp.

Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.

Recent Insider Trades

NameTypeSharesPriceDate
HRT FINANCIAL LP S-Sale 7,868 $1.29 2026-01-16
HRT FINANCIAL LP P-Purchase 29,036 $1.40 2026-01-15
HRT FINANCIAL LP 0 — 2026-01-15

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms